You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
僑雄國際(00381.HK)有意收購金迪克生物若干股權
格隆匯 03-10 12:43

格隆匯3月10日丨僑雄國際(00381.HK)宣佈,於2021年3月10日,公司與趙靜、侯雲德、李正軍及葛繼乾(統稱“賣方”)就可能收購事項訂立諒解備忘錄。根據諒解備忘錄,公司有意向賣方收購目標公司北京金迪克生物技術研究所的若干股權。

目標公司主要從事生物藥物、疫苗、診斷製劑的技術開發、技術轉讓、技術諮詢、技術服務等。目前具備四大平台技術:1、新型疫苗研發平台技術;2、新型基因藥物研發平台技術;3、病原體基因和蛋白質芯片平台技術;4、新型滾環擴增(Rolling Circle Amplification, RCA)技術平台。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account